Related Experiment Video
Updated: Jul 11, 2025
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Epidemiology, comorbidity, and use of systemic therapies in patients with paediatric psoriasis in Germany
Mona Biermann1, Benjamin Kolb1
1Novartis Pharma GmbH, Nuremberg, Germany.
Insights
Paediatric psoriasis prevalence and incidence in Germany remained stable from 2014-2017. Higher rates were seen in females and older children, with obesity and somatoform disorders as common comorbidities.
Area of Science:
- Dermatology
- Epidemiology
- Public Health
Background:
- Psoriasis presents a significant physical and psychosocial burden.
- Epidemiological data for paediatric psoriasis in Germany is limited.
- This study addresses the lack of recent data on paediatric psoriasis in Germany.
Purpose of the Study:
- To determine the prevalence and incidence of paediatric psoriasis in Germany.
- To identify associated epidemiological features, including comorbidities and treatment patterns.
- To analyze trends using national health claims data from 2014-2017.
Main Methods:
- Analysis of continuously insured patients aged 17 years or younger diagnosed with psoriasis between 2014 and 2017.
- Utilized health claims data from the Institute of Applied Health Research Berlin (InGef).
- Examined prevalence, incidence, comorbidities, medical specialties involved, and systemic treatment prescriptions.
Main Results:
- Psoriasis prevalence (0.15-0.16%) and incidence (0.06-0.07%) were stable between 2014-2017.
- Prevalence and incidence were higher in females and increased with age.
- Obesity (11.5%) and somatoform disorders (7.0%) were the most frequent comorbidities; systemic treatment use rose slightly.
Conclusions:
- Paediatric psoriasis prevalence and incidence in Germany remained stable during the study period.
- Female sex and older adolescence were associated with higher rates.
- Interdisciplinary management is crucial, involving general practitioners, dermatologists, and paediatricians.
Introduction:
Psoriasis is a chronic, inflammatory disorder with a physical and psychosocial burden. Recent epidemiological data on paediatric psoriasis in Germany is lacking. The aim of this study was to examine the prevalence, the incidence and associated epidemiological features of paediatric psoriasis in Germany using health claims data from a national health claims database.
Methods:
Continuously insured patients with paediatric psoriasis (2014-2017) from the Institute of Applied Health Research Berlin (InGef) database were included in this analysis. Between 2014 and 2017, we analysed the prevalence and incidence of paediatric psoriasis (aged ≤17 years), relevant comorbidities, the most frequently attended and diagnosing medical specialties, and the number of systemic treatment prescriptions.
Results:
Overall, psoriasis prevalence (0.15-0.16%) and incidence (0.06-0.07%) remained stable between 2014 and 2017; both prevalence and incidence were higher in female patients. Psoriasis prevalence gradually increased with age between the age groups <6 years and 16-17 years. Obesity (11.5%) and somatoform disorders (7.0%) were the most common comorbidities identified. Overall, 90.4% of the psoriasis cases were diagnosed by either a dermatologist (50.9%), general practitioner (27.8%), or paediatrician (11.7%). Patients most frequently attended general practitioners (74.5%), dermatologists (57.9%) and paediatricians (56.5%). The use of systemic treatment(s) increased from 4.7% to 5.4% between 2014 and 2017.
Discussion:
The prevalence and incidence of paediatric psoriasis in Germany remained stable between 2014 and 2017, with a higher prevalence and incidence observed in females and older adolescents. Obesity and somatoform disorders were the most common comorbidities. General practitioners, dermatologists, and paediatricians were most often involved in the treatment of patients, highlighting the need for interdisciplinary management of paediatric psoriasis.
More Related Videos
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:19Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:28Fungal Phylum Microsporidia